TH152843A - - Google Patents

Info

Publication number
TH152843A
TH152843A TH1401003357A TH1401003357A TH152843A TH 152843 A TH152843 A TH 152843A TH 1401003357 A TH1401003357 A TH 1401003357A TH 1401003357 A TH1401003357 A TH 1401003357A TH 152843 A TH152843 A TH 152843A
Authority
TH
Thailand
Prior art keywords
nanoparticles
involves
eminently
regards
mammals
Prior art date
Application number
TH1401003357A
Other languages
English (en)
Thai (th)
Original Assignee
นายจักรพรรดิ์ มงคลสิทธิ์ นางสาวปรับโยชน์ ศรีกิจจาภรณ์ นายรุทร นพคุณ
Filing date
Publication date
Application filed by นายจักรพรรดิ์ มงคลสิทธิ์ นางสาวปรับโยชน์ ศรีกิจจาภรณ์ นายรุทร นพคุณ filed Critical นายจักรพรรดิ์ มงคลสิทธิ์ นางสาวปรับโยชน์ ศรีกิจจาภรณ์ นายรุทร นพคุณ
Publication of TH152843A publication Critical patent/TH152843A/th

Links

TH1401003357A 2012-12-17 TH152843A (enExample)

Publications (1)

Publication Number Publication Date
TH152843A true TH152843A (enExample) 2016-06-07

Family

ID=

Similar Documents

Publication Publication Date Title
Laurent et al. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles
HK1203353A1 (en) Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
EP4124624A3 (en) Antibodies against canine pd-1
WO2010048623A3 (en) Medical and imaging nanoclusters
BR112015015319A2 (pt) composições de nanopartícula de albumina e paclitaxel
MX2012010253A (es) Composiciones y metodos para tratar y/o prevenir enfermedad cardiovascular.
EP4385572A3 (en) Bispecific antibody capable of being combined with immune cells to enhance tumor killing capability, and preparation method therefor and application thereof
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
WO2015067570A3 (en) Pharmaceutical combinations comprising cd33 antibodies and de-methylating agents
CO6791606A2 (es) Composiciones y métodos para el tratamiento en aplicaciones clínicas de amplio espectro, no diferenciadas o combinadas
WO2012017324A3 (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
FR3009645B1 (fr) Compositions de nanoparticules d'oxydes metalliques transparents, procedes de fabrication de celles-ci et articles comprenant celles-ci
BR112014015331A8 (pt) materiais hemostáticos e dispositivos com particulados galvânicos
EP2851446A4 (en) RESOURCE-SAVING TITANIUM ALLOYING ELEMENT WITH EXCELLENT STRENGTH AND TENSILE AND METHOD FOR PRODUCING THEREOF
Fox et al. The use of doppelgangers to promote health and behavior change
JP2012528941A5 (enExample)
WO2017079403A3 (en) Polymeric nanoparticles
EP3581653A3 (en) Methods and compositions for treating cancer using peptide nucleic acid-based agents
EP3725331A4 (en) MODIFIED CARBON NANOMATERIAL, NANOAGGREGATE, VECTOR OF SUBSTANCE DELIVERY, AND PHARMACEUTICAL COMPOSITION
TH152843A (enExample)
PT2895192T (pt) Uma composição farmacêutica compreendendo uma nanopartícula sólida e pelo menos um antígeno para o tratamento contra um agente patogénico intracelular
FR3002414B1 (fr) Composition rodenticide sous forme de cereales et/ou de graines agglomerees.
BR112012006267A2 (pt) processo para produzir partículas de substrato orgânico ligadas a nanopartículas ferromagnéticas comutáveis, partículas de substrato para diagnóstico, uso de nanopartículas ferromagnéticas comutáveis, e, medicamento para o tratamento de hipertermia no corpo humano ou animal
IN2014DN11097A (enExample)
Ibrahim et al. Light scattering from a cluster consists of layered axisymmetric objects